A prospective study on newborn screening for spinal muscular atrophy and severe combined immunodeficiency in Eastern Andalusia. IP: Raquel Yahyaoui. Promotor: FIMABIS-IBIMA. Entidad financiadora: Novartis Gene Therapies. Duración: 16/02/2021-16/08/22.
- 4 marzo, 2021
- /
- 0